
Orchid Pharma Q2 FY27 Results: Consolidated Net Profit ₹28.59 Crore on Total Income of ₹359 Crore
Orchid Pharma (NSE: ORCHPHARMA) reported consolidated total income of ₹359.02 crore and net profit of ₹28.59 crore for the quarter ended 30 Sep 2026, and standalone total income of ₹369.90 crore and net profit of ₹36.76 crore, it said in a filing on 14 Nov 2026.
- Earnings
- pharmaceuticals